CD40LG and hemolytic-uremic syndrome: Since we found a negative correlation between plasma sCD40L concentration and urea and creatinine levels in HUS patients, and considering that sCD40L levels per platelet were higher in HUS patients that HC, we propose that sCD40L could represent an alternative marker of platelet activation in those cases in which thrombocytopenia is not evident.